- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01836835
Pregnancy Specific Nausea Questionnaire (PUQE) Translated and Tested in Norwegian (PUQE-N)
Case-cohort Validation Study of Pregnancy Unique Questionnaire of Emesis (PUQE) in Norwegian
Study Overview
Status
Conditions
Detailed Description
This is a prospective case-control study validating Pregnancy Unique Questionnaire of Emesis (PUQE) in a Norwegian population. The questionnaire has been translated from English to Norwegian by authorized translators. The Norwegian questionnaire's title is Svangerskaps Utløst Kvalme Kvantifisering (SUKK). The Norwegian version has been independently back-translated to English. The back-translated version has been approved by the original author Gideon Koren.
The primary objective is to evaluate if the questionnaire score is significantly different between a group of presumed healthy pregnant woman and a group of patients hospitalized with hyperemesis gravidarum.
The women will also fill in a self-reported 24-hours nutritional intake diary and this will be related to the Pregnancy Unique Questionnaire of Emesis (PUQE)score. For patients hospitalized with hyperemesis gravidarum the Pregnancy Unique Questionnaire of Emesis (PUQE)score both at admission and discharge will be compared.
Background clinical information for both groups at enrollment will be recorded as well as pregnancy outcome for woman and child.
The study has been approved by the Institutional Board as well as the Norwegian Regional Ethical Committee (REK Norway). Women will be included after giving informed written consent. Data will be stored electronically, anonymised, at a designated research server in accordance with the institutional research rules.
The sample size have been determined on basis of a similar study evaluating different nutritional status in emesis and hyperemesis patients, using 20 patients in each group. We aim to include 30 patients in each group.
Patients with diagnose of Hyperemesis gravidarum admitted form 1st of May 2013 will be consecutively asked to participate. Control patients will be recruited by invitation at primary care facilities or private out-patient gynaecologists.
Statistical analyses will be performed using Statistical Package for the Social Sciences (SPSS). Categorical variables will be compared using Chi-square test and continuous variables by non-parametric tests. Paired test will be used when comparing Pregnancy Unique Questionnaire of Emesis (PUQE)scores sequentially from admittance to discharge.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Hordaland
-
Bergen, Hordaland, Norway, 5021
- Dpt. of Obstetrics and Gynaecology, Haukeland University Hospital
-
-
Rogaland
-
Stavanger, Rogaland, Norway, 4000
- Dpt Obstetrics Gynaecology, Stavanger University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Hyperemesis patients; recruited from university hospital clinic (normally 60 patients admitted during 12 months)
Control paitients recruited from primary care/private practice out-patient gynaecologists
Description
Inclusion Criteria:
- Pregnant healthy women (controls)
- Patients admitted to hospital for hyperemesis gravidarum
Exclusion Criteria:
- Pregnancy duration at inclusion more than 16 weeks
- Unable to understand and read/write Norwegian
- Conditions other than hyperemesis leading to nausea/vomiting
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Hyperemesis gravidarum
Women diagnosed with hyperemesis gravidarum admitted to hospital Pregnancy Unique Questionnaire of Emesis (PUQE) and 24 hours self-reported nutritional intake form administered
|
For hyperemesis gravidarum patients the Pregnancy Unique Questionnaire of Emesis (PUQE) (3 questions regarding the amount of nausea and vomiting during 24 hours) will be answered both at hospital admittance and discharge.
For control patients the questionnaire will be answered at inclusion.
A nutritional intake form where relevant food and liquid items can be checked prospectively after consummation during 24 hours.
This form will be filled in starting the morning following inclusion.
|
|
Healthy pregnant women
Women with presumed normal pregnancy Pregnancy Unique Questionnaire of Emesis (PUQE) and 24 hours self-reported nutritional intake form administered
|
For hyperemesis gravidarum patients the Pregnancy Unique Questionnaire of Emesis (PUQE) (3 questions regarding the amount of nausea and vomiting during 24 hours) will be answered both at hospital admittance and discharge.
For control patients the questionnaire will be answered at inclusion.
A nutritional intake form where relevant food and liquid items can be checked prospectively after consummation during 24 hours.
This form will be filled in starting the morning following inclusion.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pregnancy Unique Questionnaire of Emesis (PUQE) score reported by hyperemesis patients versus normal pregnant women
Time Frame: 24 hours after inclusion
|
Pregnancy Unique Questionnaire of Emesis (PUQE) score range from 3 to 15. Scores reported for the first 24 hours after inclusion will be compared between hyperemesis patients and healthy pregnant control women
|
24 hours after inclusion
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pregnancy Unique Questionnaire of Emesis (PUQE) score in relation to self reported 24 hours nutritional intake registration (estimated caloric intake)in hyperemesis patients versus normal pregnant women
Time Frame: 24 hours after inclusion
|
The Pregnancy Unique Questionnaire of Emesis (PUQE) scores from hyperemesis and control women will be compared to self-reported 24 hours nutritional intake
|
24 hours after inclusion
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Pregnancy Unique Questionnaire of Emesis (PUQE) score from hospital admittance to discharge
Time Frame: From hospital admission to discharge, mean 7 days
|
Change in Pregnancy Unique Questionnaire of Emesis (PUQE) score for hyperemesis gravidarum patients from first assessment at hospital admission and again at hospital discharge
|
From hospital admission to discharge, mean 7 days
|
|
Pregnancy Unique Questionnaire of Emesis (PUQE) score at inclusion related to change in patient weight (kg)from start of pregnancy to inclusion for hyperemesis patients versus normal pregnant women
Time Frame: From pre-pregnancy to inclusion (mean 9 weeks pregnancy length)
|
Change of weight (gain or loss) from pre-pregnant to time of inclusion related to Pregnancy Unique Questionnaire of Emesis (PUQE) scores for hyperemesis and control women
|
From pre-pregnancy to inclusion (mean 9 weeks pregnancy length)
|
|
Change of Pregnancy Unique Questionnaire of Emesis (PUQE) score and patient weight (kg)
Time Frame: From inclusion to delivery (mean 7 months)
|
Change of weight (gain or loss) from inclusion to time of delivery related to Pregnancy Unique Questionnaire of Emesis (PUQE) scores at inclusion for hyperemesis and control women
|
From inclusion to delivery (mean 7 months)
|
|
Pregnancy Unique Questionnaire of Emesis (PUQE) score related to the baby's weight (kg)in hyperemesis patients versus normal pregnant women
Time Frame: From inclusion to delivery (mean 7 months)
|
Pregnancy Unique Questionnaire of Emesis (PUQE) scores at inclusion for hyperemesis versus control women is related to the baby's weight at delivery
|
From inclusion to delivery (mean 7 months)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jone Trovik, MD, PhD, Haukeland University Hospital
Publications and helpful links
General Publications
- Lacasse A, Rey E, Ferreira E, Morin C, Berard A. Validity of a modified Pregnancy-Unique Quantification of Emesis and Nausea (PUQE) scoring index to assess severity of nausea and vomiting of pregnancy. Am J Obstet Gynecol. 2008 Jan;198(1):71.e1-7. doi: 10.1016/j.ajog.2007.05.051.
- Koren G, Piwko C, Ahn E, Boskovic R, Maltepe C, Einarson A, Navioz Y, Ungar WJ. Validation studies of the Pregnancy Unique-Quantification of Emesis (PUQE) scores. J Obstet Gynaecol. 2005 Apr;25(3):241-4. doi: 10.1080/01443610500060651.
- van Stuijvenberg ME, Schabort I, Labadarios D, Nel JT. The nutritional status and treatment of patients with hyperemesis gravidarum. Am J Obstet Gynecol. 1995 May;172(5):1585-91. doi: 10.1016/0002-9378(95)90501-4.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2013/465
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hyperemesis Gravidarum
-
Kayseri Education and Research HospitalUnknown
-
University of CalgaryCanadian Institutes of Health Research (CIHR)Completed
-
Nordsjaellands HospitalOdense University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark; Hvidovre University Hospital and other collaboratorsTerminatedHyperemesis Gravidarum | Nausea Gravidarum | Vomiting of PregnancyDenmark
-
Kayseri Education and Research HospitalUnknown
-
Mercy Health OhioLake Erie College of Osteopathic MedicineRecruitingCannabis Hyperemesis SyndromeUnited States
-
Nawaz Sharif Medical CollegeUniversity of GujratNot yet recruitingHyperemesis Gravidarum | Nausea GravidarumPakistan
-
Kayseri Education and Research HospitalCompletedGestational Diabetes | Hyperemesis; Gravidarum, With Dehydration
-
Tasnem Abo-elouonAssiut UniversityCompletedHyperemesis GravidarumEgypt
-
Universiti Kebangsaan Malaysia Medical CentreCompleted
-
Batman Training and Research HospitalCompletedCorneal Dystrophy | Macular Dystrophy | Hyperemesis Gravidarum - SevereTurkey
Clinical Trials on Pregnancy Unique Questionnaire of Emesis (PUQE)
-
Haukeland University HospitalUniversity of BergenUnknownPregnancy | Hyperemesis GravidarumNorway
-
Electromedical Products International, Inc.Completed
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker CochinCompletedJuvenile DermatomyositisFrance
-
Medical University InnsbruckCompletedWounds and Injuries | Foreign-Body Reaction | Tissue Expander Disorder | Capsular Contracture Associated With ImplantAustria
-
Assistance Publique - Hôpitaux de ParisUnknownSmoking | Carcinogenesis of the NicotineFrance
-
University of WashingtonNational Cancer Institute (NCI)TerminatedNausea and Vomiting | Stage III Squamous Cell Carcinoma of the Hypopharynx | Stage III Squamous Cell Carcinoma of the Larynx | Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity | Stage III Squamous Cell Carcinoma of the Nasopharynx | Stage III Squamous Cell Carcinoma of the Oropharynx and other conditionsUnited States
-
Nantes University HospitalPays de la Loire Laboratory of Psychology (LPPL); Physiopathology of Nutritional... and other collaboratorsRecruitingNeurodevelopmental Disorder | Heart Disease CongenitalFrance
-
Medical University of ViennaRecruitingAsthma | Chronic Rhinosinusitis (Diagnosis) | Nasal Polyps | Chronic Rhinosinusitis With Nasal PolypsAustria
-
LiveKidney.BioMedical University of South Carolina; Galilee CBRRecruitingSystemic Lupus Erythematosus | SLE | Systemic Lupus Erythematosus (SLE) | Lupus | Systemic Lupus ErthematosusUnited States
-
Anchora MedicalCompleted